Abstract
This commentary reports on the history of tumor-infiltrating lymphocytes (TIL) for adoptive cell therapy and where TIL fits into the treatment options for metastatic melanoma.
MeSH terms
-
Humans
-
Immunotherapy, Adoptive / methods
-
Lymphocytes, Tumor-Infiltrating
-
Melanoma* / drug therapy
-
Melanoma* / immunology
-
Melanoma* / pathology
-
Melanoma* / therapy
-
T-Lymphocytes / immunology
-
United States
-
United States Food and Drug Administration*